Comments
Bliss GVS Pharma has completed the commissioning and qualification of phase-I for its new multi-product facility at Palghar East in Maharashtra. This is the largest manufacturing unit of the company in terms of planned production capacity when completed, it said in a notice to the stock exchanges. The facility is equipped with process equipment and utilities with a large part of the manufacturing process automated for enhanced levels of productivity, efficiency and compliance while reducing manual intervention. The unit is spread on an overall area of about two lakh sq ft and is intended to further augment the production capacities for the company. The stock jumped 5.27 per cent at ₹103.95 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.